Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-012930)

Filing Details

Accession Number:: 0000899243-17-012930
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-11 20:30:39
Reporting Period:: 2017-05-10

Filing Date:: 2017-05-11
Accepted Time:: 2017-05-11 20:30:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404281	Novus Therapeutics Inc.	NVUS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280154	Christine Ocampo	C/O Novus Therapeutics, Inc. 19900 Macarthur Blvd., Suite 550 Irvine CA 92612	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-10	10,010	$9.99	21,590	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

All numbers give effect to the 1:9 reverse stock split effected by the Company on May 11, 2017.